\(
\def\WIPO{World Intellectual Property Organisation}
\)
Generic drug entry prior to patent expiration : an FTC study / Federal Trade Commission.
2003
G 25 FTC. G
Available at WIPO Library
Форматы
| Формат | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Полное описание
Название
Generic drug entry prior to patent expiration : an FTC study / Federal Trade Commission.
Описание
xi, 68, 45 pages ; 23 cm.
ISBN
1575887452 alk. paper
9781575887456 alk. paper
9781575887456 alk. paper
Альтернативный идентификационный номер
G 25 FTC. G
Примечание
Originally published: Washington, D.C. : Federal Trade Commission, 2002.
Запись форматированного содержания
1. Introduction and background; 2. Outcomes of patent infringement lawsuits under the Hatch-Waxman amendments; 3. Settlements related to paragraph IV certifications; 4. Orange book patent listing practices and use of multiple 30-month stays; 5. 180-day marketing exclusivity under the Hatch-Waxman amendments; 6. FDA citizen petitions and generic drug applications.
Introduction and background
Outcomes of patent infringement lawsuits under the Hatch-Waxman amendments
Settlements related to Paragraph IV certifications
Orange book patent listing practices and use of multiple 30-month stays
180-day marketing exclusivity under the Hatch-Waxman amendments
FDA citizen petitions and generic drug applications.
Introduction and background
Outcomes of patent infringement lawsuits under the Hatch-Waxman amendments
Settlements related to Paragraph IV certifications
Orange book patent listing practices and use of multiple 30-month stays
180-day marketing exclusivity under the Hatch-Waxman amendments
FDA citizen petitions and generic drug applications.
Серии
Hein's electronic documents reprint series ; title 9.
Опубликовано
Buffalo, N.Y. : W.S. Hein, 2003.
Язык(и)
eng
Запись имеется в